Lascufloxacin switch therapy versus ampicillin/sulbactam for older patients with community-acquired pneumonia in Japan (STEP study): a study protocol for a multicentre open-label randomised controlled non-inferiority trial.
- DOI
- 10.1136/bmjopen-2026-116633
- Published
- 2026 Jun 30
- Container
- BMJ open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2026-116633,
title = {Lascufloxacin switch therapy versus ampicillin/sulbactam for older patients with community-acquired pneumonia in Japan (STEP study): a study protocol for a multicentre open-label randomised controlled non-inferiority trial.},
author = {Takeda K and Takazono T and Ashizawa N and Yoshida M and Ide S and Iwanaga N and Hirano K and Hosogaya N and Komiya K and Izumikawa K and Yanagihara K and Mukae H},
year = {2026},
journal = {BMJ open},
doi = {10.1136/bmjopen-2026-116633},
url = {https://doi.org/10.1136/bmjopen-2026-116633}
}RIS
TY - JOUR TI - Lascufloxacin switch therapy versus ampicillin/sulbactam for older patients with community-acquired pneumonia in Japan (STEP study): a study protocol for a multicentre open-label randomised controlled non-inferiority trial. AU - Takeda K AU - Takazono T AU - Ashizawa N AU - Yoshida M AU - Ide S AU - Iwanaga N AU - Hirano K AU - Hosogaya N AU - Komiya K AU - Izumikawa K AU - Yanagihara K AU - Mukae H PY - 2026 JO - BMJ open DO - 10.1136/bmjopen-2026-116633 UR - https://doi.org/10.1136/bmjopen-2026-116633 ER -
APA
K, T., T, T., N, A., M, Y., S, I., N, I., K, H., N, H., K, K., K, I., K, Y., & H, M. (2026). Lascufloxacin switch therapy versus ampicillin/sulbactam for older patients with community-acquired pneumonia in Japan (STEP study): a study protocol for a multicentre open-label randomised controlled non-inferiority trial.. BMJ open. https://doi.org/10.1136/bmjopen-2026-116633
Source records
- pubmed · retrieved 2026-09-26T15:41:54.540Z
- europe-pmc · retrieved 2026-09-26T15:41:54.546Z
- doaj · retrieved 2026-09-26T15:41:54.554Z